La Jolla, CA, United States of America

Robert Quinn

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Quinn. Retrieved from https://idiyas.com/inventor/robert-quinn-vknixvol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Quinn

Introduction

Robert Quinn is a notable inventor based in La Jolla, California. He has made significant contributions to the field of medical science, particularly in the treatment of diseases through the modulation of bile acids. His work is characterized by a commitment to advancing healthcare solutions.

Latest Patents

Robert Quinn holds a patent for "Bile acids and use in disease treatment." This patent focuses on compositions and methods for modulating bile acids, including phenylalanocholic acid, tyrosocholic acid, and leucocholic acid. These innovations aim to treat diseases such as inflammatory bowel disease. The invention provides pharmaceutical compositions that modulate levels of a bile acid conjugate in a subject, targeting specific organs or bodily regions.

Career Highlights

Quinn is affiliated with the University of California, where he continues to engage in groundbreaking research. His work has the potential to impact the treatment of various gastrointestinal diseases, showcasing his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include Pieter Dorrestein and Alexey Melnik. Their collaborative efforts contribute to the advancement of research in the field of bile acid modulation.

Conclusion

Robert Quinn's innovative work in bile acid modulation represents a significant advancement in medical treatments. His contributions are poised to enhance the understanding and management of inflammatory bowel disease and other related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…